| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.69▲ | 4.61▲ | 4.61▲ | 4.56▲ | 3.86▲ |
| MA10 | 4.64▲ | 4.58▲ | 4.59▲ | 4.36▲ | 2.74▲ |
| MA20 | 4.60▲ | 4.56▲ | 4.50▲ | 3.66▲ | 2.61▲ |
| MA50 | 4.57▲ | 4.44▲ | 4.35▲ | 2.50▲ | 1.28▲ |
| MA100 | 4.55▲ | 4.32▲ | 3.53▲ | 2.42▲ | 0.98▲ |
| MA200 | 4.42▲ | 3.25▲ | 2.88▲ | 1.36▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 0.007▲ | 0.004▲ | 0.079▲ | 0.244▲ |
| RSI | 87.105▲ | 72.957▲ | 68.329▲ | 75.696▲ | 78.689▲ |
| STOCH | 99.495▲ | 54.831 | 55.903 | 83.998▲ | 73.607 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -3.000▲ | -1.478▲ |
| CCI | 220.422▲ | 294.203▲ | 224.272▲ | 90.741 | 176.774▲ |
|
Friday, May 16, 2025 03:00 AM
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported first quarter 2025 financial ...
|
|
Thursday, May 15, 2025 05:06 PM
OST-HER2, an off-the-shelf immunotherapy ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
|
|
Thursday, May 15, 2025 03:00 AM
OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced the launch of OS Animal ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/05/25 | 4.45 | 4.78 | 4.45 | 4.78 | 1,691,459 |
| 19/05/25 | 4.50 | 4.70 | 4.45 | 4.59 | 2,071,536 |
| 16/05/25 | 4.24 | 4.60 | 4.00 | 4.56 | 6,165,491 |
| 15/05/25 | 4.25 | 4.50 | 4.25 | 4.47 | 753,244 |
| 14/05/25 | 4.30 | 4.42 | 4.14 | 4.41 | 1,225,360 |
| 13/05/25 | 4.73 | 4.84 | 4.03 | 4.35 | 2,358,009 |
| 12/05/25 | 4.03 | 4.48 | 4.00 | 4.38 | 7,164,905 |
| 09/05/25 | 4.08 | 4.3765 | 3.97 | 4.14 | 27,399 |
| 08/05/25 | 3.77 | 4.316 | 3.6426 | 4.16 | 102,608 |
| 07/05/25 | 2.87 | 3.87 | 2.84 | 3.75 | 321,228 |
|
|
||||
|
|
||||
|
|